We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes two clinical-stage programs (ERK and SHP2 inhibitors), two preclinical-stage progr... Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes two clinical-stage programs (ERK and SHP2 inhibitors), two preclinical-stage programs (CNS-penetrant KRAS G12C and EGFR inhibitors), and seven discovery-stage programs targeting other key oncogenic drivers. Show more
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.11 | -5.21327014218 | 2.11 | 2.44 | 1.97 | 879874 | 2.23153134 | CS |
| 4 | -0.21 | -9.50226244344 | 2.21 | 2.588 | 1.96 | 705865 | 2.14510608 | CS |
| 12 | 0.25 | 14.2857142857 | 1.75 | 2.655 | 1.64 | 806863 | 2.12747655 | CS |
| 26 | -0.38 | -15.9663865546 | 2.38 | 2.655 | 1.51 | 968318 | 2.02007217 | CS |
| 52 | -1 | -33.3333333333 | 3 | 3.375 | 1.51 | 805316 | 2.26682902 | CS |
| 156 | -13.9 | -87.4213836478 | 15.9 | 24.47 | 1.51 | 731746 | 6.08041293 | CS |
| 260 | -13.9 | -87.4213836478 | 15.9 | 24.47 | 1.51 | 731746 | 6.08041293 | CS |
glenn1919
2 weeks ago
Monksdream
2 months ago
ice trader
2 months ago
Monksdream
6 months ago
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
